Gallego, Alejandro http://orcid.org/0000-0002-5556-0449
Beato, Carmen
Brozos, Elena
De La Cruz, Susana
García, Ruth Vera
Funding for this research was provided by:
Universidad de Navarra
Article History
Received: 11 June 2024
Accepted: 12 June 2024
First Online: 8 July 2024
Declarations
:
: Alejandro Gallego declares receipt of honoraria or consultation fees from GSK, MSD, AstraZeneca, and Clovis; participation in speakers bureau for Roche, AstraZeneca, MSD, Clovis, and GSK; and travel/accommodation/expenses from Roche, MSD, GSK, AstraZeneca, and PharmaMar. Carmen Beato declares that they have no conflicts of interest. Elena Brozos declares consultancy or advisory honoraria from Bayer, Pfizer, and Servier; travel and accommodation expenses from Amgen, Lilly and Company, Daiichi Sankyo, LEO Pharma, Merck, Pfizer, Roche, Rovi, Sanofi, and Servier; and payment or honoraria for educational activities from Amgen, Bayer, Kyowa Kirin, LEO Pharma, Merck, Pierre Fabre, Rovi, Roche, and Sanofi. Susana De La Cruz declares consulting fees and honoraria from AstraZeneca, Daiichi Sankyo, Pfizer, Lilly, Novartis, Seagen, Gilead, and Adamed; travel grants from Pfizer, Novartis, AstraZeneca, and Gilead; and advisory roles for Pfizer, AstraZeneca, Daiichi Sankyo, and Seagen<b>.</b> Ruth Vera García declares honoraria from or acted in an advisory role for Roche, Sanofi, MSD, Merck, Eisai, Novartis, Pierre Fabre, Lilly, BAXTER, and ABBOTT; funding for educational or research programs from Roche, Lilly and MSD, as well as payment of travel/accommodation expenses from Roche, Merck, Sanofi, Pierre Fabre, and MSD.
: The manuscript does not contain clinical studies or patient data.
: Not applicable.
: Not applicable.